120 related articles for article (PubMed ID: 16343858)
1. Pharmacokinetic-pharmacodynamic aspects of antimicrobial prophylaxis with teicoplanin in patients undergoing major vascular surgery.
Pea F; Furlanut M; Stellini R; Bonardelli S; Signorini L; Pavan F; Matheis A; Portolani N; Lorenzotti S; Giulini SM; Viale P; Carosi G
Int J Antimicrob Agents; 2006 Jan; 27(1):15-9. PubMed ID: 16343858
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of teicoplanin for the prevention of surgical site infections after total hip or knee arthroplasty: a prospective, open-label study.
Kanellakopoulou K; Papadopoulos A; Varvaroussis D; Varvaroussis A; Giamarellos-Bourboulis EJ; Pagonas A; Stergiou A; Papadelis P; Nikolaidis V; Giamarellou H
Int J Antimicrob Agents; 2009 May; 33(5):437-40. PubMed ID: 19117731
[TBL] [Abstract][Full Text] [Related]
3. Recommendations to achieve rapid therapeutic teicoplanin plasma concentrations in adult hospitalised patients treated for sepsis.
Brink AJ; Richards GA; Cummins RR; Lambson J;
Int J Antimicrob Agents; 2008 Nov; 32(5):455-8. PubMed ID: 18718742
[TBL] [Abstract][Full Text] [Related]
4. Teicoplanin therapeutic drug monitoring in critically ill patients: a retrospective study emphasizing the importance of a loading dose.
Pea F; Brollo L; Viale P; Pavan F; Furlanut M
J Antimicrob Chemother; 2003 Apr; 51(4):971-5. PubMed ID: 12654757
[TBL] [Abstract][Full Text] [Related]
5. Loading dose required to achieve rapid therapeutic teicoplanin trough plasma concentration in patients with multidrug-resistant gram-positive infections.
Wang JT; Liao HI; Wu Lin FL; Chang SC
Basic Clin Pharmacol Toxicol; 2012 May; 110(5):416-20. PubMed ID: 22309355
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic studies of linezolid and teicoplanin in the critically ill.
Whitehouse T; Cepeda JA; Shulman R; Aarons L; Nalda-Molina R; Tobin C; MacGowan A; Shaw S; Kibbler C; Singer M; Wilson AP
J Antimicrob Chemother; 2005 Mar; 55(3):333-40. PubMed ID: 15705641
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of teicoplanin during cardiopulmonary bypass surgery.
Mini E; Mazzei T; Reali EF; Novelli A; Periti P
Int J Clin Pharmacol Res; 1989; 9(4):287-92. PubMed ID: 2528510
[TBL] [Abstract][Full Text] [Related]
8. Teicoplanin vs cephradine and metronidazole in the prophylaxis of sepsis following vascular surgery: an interim analysis of an ongoing trial.
Antrum RM; Galvin K; Gorst K; Thornton CA; Lansdown M; Kester RC
Eur J Surg Suppl; 1992; (567):43-6. PubMed ID: 1381643
[TBL] [Abstract][Full Text] [Related]
9. Glycopeptide pharmacokinetics in current paediatric cardiac surgery practice.
Shime N; Kato Y; Kosaka T; Kokufu T; Yamagishi M; Fujita N
Eur J Cardiothorac Surg; 2007 Oct; 32(4):577-81. PubMed ID: 17689968
[TBL] [Abstract][Full Text] [Related]
10. Development of teicoplanin dosage guidelines for patients treated within an outpatient parenteral antibiotic therapy (OPAT) programme.
Lamont E; Seaton RA; Macpherson M; Semple L; Bell E; Thomson AH
J Antimicrob Chemother; 2009 Jul; 64(1):181-7. PubMed ID: 19411678
[TBL] [Abstract][Full Text] [Related]
11. Population pharmacokinetics of teicoplanin and attainment of pharmacokinetic/pharmacodynamic targets in adult patients with haematological malignancy.
Byrne CJ; Roberts JA; McWhinney B; Ryder SA; Fennell JP; O'Byrne P; Deasy E; Egan S; Desmond R; Enright H; D'Arcy DM; McHugh J
Clin Microbiol Infect; 2017 Sep; 23(9):674.e7-674.e13. PubMed ID: 28267636
[TBL] [Abstract][Full Text] [Related]
12. Teicoplanin levels in bone and joint infections: are standard doses subtherapeutic?
Matthews PC; Taylor A; Byren I; Atkins BL
J Infect; 2007 Nov; 55(5):408-13. PubMed ID: 17825421
[TBL] [Abstract][Full Text] [Related]
13. Regional and systemic prophylaxis with teicoplanin in total knee arthroplasty: a tissue penetration study.
Lazzarini L; Novelli A; Marzano N; Timillero L; Fallani S; Viola R; de Lalla F
J Arthroplasty; 2003 Apr; 18(3):342-6. PubMed ID: 12728428
[TBL] [Abstract][Full Text] [Related]
14. Teicoplanin in patients with acute leukaemia and febrile neutropenia: a special population benefiting from higher dosages.
Pea F; Viale P; Candoni A; Pavan F; Pagani L; Damiani D; Casini M; Furlanut M
Clin Pharmacokinet; 2004; 43(6):405-15. PubMed ID: 15086277
[TBL] [Abstract][Full Text] [Related]
15. Intravitreal penetration of teicoplanin.
Briggs MC; McDonald P; Bourke R; Smith G; McGalliard JN; Wong D
Eye (Lond); 1998; 12 ( Pt 2)():252-5. PubMed ID: 9683949
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of vancomycin, teicoplanin and fusidic acid as prophylactic agents in prevention of vascular graft infection: an experimental study in rat.
Yasim A; Gul M; Atahan E; Ciragil P; Aral M; Ergun Y
Eur J Vasc Endovasc Surg; 2006 Mar; 31(3):274-9. PubMed ID: 16360328
[TBL] [Abstract][Full Text] [Related]
17. Serum and bone concentrations of teicoplanin and vancomycin: study in an animal model.
Drago L; De Vecchi E; Fassina MC; Gismondo MR
Drugs Exp Clin Res; 1998; 24(4):185-90. PubMed ID: 10051964
[TBL] [Abstract][Full Text] [Related]
18. The effect of multifactorial, multidisciplinary educational interventions on appropriate use of teicoplanin.
Pea F; Viale P; Pavan F; Tavio M; Poz D; Beltrame A; Furlanut M
Int J Antimicrob Agents; 2006 Apr; 27(4):344-50. PubMed ID: 16554146
[TBL] [Abstract][Full Text] [Related]
19. Teicoplanin in cardiac surgery: intraoperative pharmacokinetics and concentrations in cardiac and mediastinal tissues.
Martin C; Bourget P; Alaya M; Sertin A; Atlani C; Ennabli K; Said R
Antimicrob Agents Chemother; 1997 May; 41(5):1150-5. PubMed ID: 9145887
[TBL] [Abstract][Full Text] [Related]
20. Age- and gender-related differences in teicoplanin levels in paediatric patients.
Strenger V; Hofer N; Rödl S; Hönigl M; Raggam R; Seidel MG; Dornbusch HJ; Sperl D; Lackner H; Schwinger W; Sovinz P; Benesch M; Urlesberger B; Urban C
J Antimicrob Chemother; 2013 Oct; 68(10):2318-23. PubMed ID: 23702837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
